From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Physician's First Watch>
  3. Medical News

Manufacture of Oral Agent for Gonorrhea Resumes

The only CDC-recommended oral treatment for gonorrhea is available for the first time since 2002, when Wyeth Pharmaceuticals stopped making it.

According to a report in MMWR, Lupin Pharmaceuticals has resumed production of the drug, cefixime (Suprax). A single 400-mg tablet is suggested for uncomplicated gonorrhea infection.

Cefixime is the only recommended oral antimicrobial to which Neisseria gonorrhoeae has not developed resistance.

LINK(S):

MMWR article (Free)

MMWR article on cefixime discontinuation in 2002 (Free)

Published in Physician's First Watch April 25, 2008

Copyright © 2008. Massachusetts Medical Society. All rights reserved.